Capital Research Global Investors’s CME Group CME Stock Holding History

Capital Research Global Investors’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$985M	Buy	3,334,426 +2,272,083	+214%	+$675M	0.15%	116
2025 Q4	$290M	Buy	1,062,343 +7,716	+0.7%	+$2.1M	0.05%	193
2025 Q3	$285M	Buy	1,054,627 +6,545	+0.6%	+$1.78M	0.05%	188
2025 Q2	$289M	Buy	1,048,082 +280,225	+36%	+$76.2M	0.06%	184
2025 Q1	$204M	Buy	767,857 +1,013	+0.1%	+$250K	0.04%	219
2024 Q4	$178M	Sell	766,844 -214,797	-22%	-$49.4M	0.04%	237
2024 Q3	$217M	Sell	981,641 -1,707,380	-63%	-$353M	0.05%	212
2024 Q2	$529M	Sell	2,689,021 -951,245	-26%	-$197M	0.12%	139
2024 Q1	$784M	Sell	3,640,266 -2,951,040	-45%	-$620M	0.18%	113
2023 Q4	$1.39B	Sell	6,591,306 -2,412,913	-27%	-$515M	0.34%	78
2023 Q3	$1.8B	Sell	9,004,219 -170,567	-2%	-$33.9M	0.5%	58
2023 Q2	$1.7B	Buy	9,174,786 +951,953	+12%	+$176M	0.46%	63
2023 Q1	$1.57B	Buy	8,222,833 +2,273,829	+38%	+$411M	0.45%	66
2022 Q4	$1B	Sell	5,949,004 -163,982	-3%	-$28.5M	0.3%	89
2022 Q3	$1.08B	Sell	6,112,986 -484,075	-7%	-$95.7M	0.36%	75
2022 Q2	$1.35B	Sell	6,597,061 -1,243,877	-16%	-$264M	0.42%	67
2022 Q1	$1.87B	Sell	7,840,938 -1,259,520	-14%	-$296M	0.46%	56
2021 Q4	$2.08B	Buy	9,100,458 +603,755	+7%	+$133M	0.46%	50
2021 Q3	$1.64B	Sell	8,496,703 -800,385	-9%	-$162M	0.38%	65
2021 Q2	$1.98B	Sell	9,297,088 -515,537	-5%	-$109M	0.46%	46
2021 Q1	$2B	Sell	9,812,625 -1,325,187	-12%	-$261M	0.49%	43
2020 Q4	$2.03B	Sell	11,137,812 -1,532	-0%	-$261K	0.53%	39
2020 Q3	$1.86B	Sell	11,139,344 -164,032	-1%	-$27.6M	0.56%	36
2020 Q2	$1.84B	Sell	11,303,376 -1,251,907	-10%	-$224M	0.58%	35
2020 Q1	$2.17B	Sell	12,555,283 -1,040,402	-8%	-$207M	0.85%	24
2019 Q4	$2.73B	Buy	13,595,685 +250,389	+2%	+$51.4M	0.82%	30
2019 Q3	$2.82B	Sell	13,345,296 -474,643	-3%	-$99.2M	0.93%	29
2019 Q2	$2.68B	Buy	13,819,939 +1,764,320	+15%	+$325M	0.85%	33
2019 Q1	$1.98B	Buy	12,055,619 +640,467	+6%	+$113M	0.63%	43
2018 Q4	$2.15B	Buy	11,415,152 +508,469	+5%	+$93.9M	0.75%	34
2018 Q3	$1.86B	Buy	10,906,683 +5,658,108	+108%	+$953M	0.54%	45
2018 Q2	$860M	Buy	5,248,575 +4,021,575	+328%	+$657M	0.24%	102
2018 Q1	$198M	Hold	1,227,000	–	–	0.06%	233
2017 Q4	$179M	Hold	1,227,000	–	–	0.05%	237
2017 Q3	$166M	Hold	1,227,000	–	–	0.05%	244
2017 Q2	$154M	Hold	1,227,000	–	–	0.05%	256
2017 Q1	$146M	Hold	1,227,000	–	–	0.05%	258
2016 Q4	$142M	Sell	1,227,000 -378,068	-24%	-$42.1M	0.05%	258
2016 Q3	$168M	Sell	1,605,068 -765,360	-32%	-$79.9M	0.06%	236
2016 Q2	$231M	Sell	2,370,428 -356,572	-13%	-$33.7M	0.08%	207
2016 Q1	$262M	Sell	2,727,000 -1,663,000	-38%	-$151M	0.09%	197
2015 Q4	$398M	Hold	4,390,000	–	–	0.14%	153
2015 Q3	$407M	Sell	4,390,000 -712,822	-14%	-$67.8M	0.15%	149
2015 Q2	$475M	Sell	5,102,822 -3,719,678	-42%	-$347M	0.16%	147
2015 Q1	$836M	Sell	8,822,500 -2,515,000	-22%	-$233M	0.29%	90
2014 Q4	$1.01B	Buy	11,337,500 +881,000	+8%	+$74.7M	0.34%	78
2014 Q3	$836M	Buy	10,456,500 +4,956,500	+90%	+$374M	0.29%	88
2014 Q2	$390M	Buy	5,500,000 +2,500,000	+83%	+$176M	0.14%	155
2014 Q1	$222M	Hold	3,000,000	–	–	0.08%	209
2013 Q4	$235M	Hold	3,000,000	–	–	0.09%	203
2013 Q3	$222M	Hold	3,000,000	–	–	0.09%	209
2013 Q2	$228M	Buy	+3,000,000	New	+$197M	0.1%	190

Other funds holding CME

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors's CME Position: Q1 2026 in Review

Capital Research Global Investors increased its CME Group (CME) stake by 214% in Q1 2026, buying an estimated $675M and bringing the position to 3,334,426 shares worth $985M. The position accounts for 0.15% of the portfolio, ranked #116.

Capital Research Global Investors first reported a position in CME in Q2 2013 and has held it in 52 quarters since. The position peaked at $2.82B in Q3 2019. 1,791 funds tracked by Wall St. Rank hold CME as of Q1 2026.

Capital Research Global Investors held 3,334,426 shares of CME Group worth $985M as of Q1 2026.
Capital Research Global Investors bought 2,272,083 CME Group shares in Q1 2026, an estimated $675M.
CME Group made up 0.15% of Capital Research Global Investors's portfolio in Q1 2026, its #116 holding.
Capital Research Global Investors first reported a position in CME Group in Q2 2013 and has held it in 52 quarters since.
Capital Research Global Investors's CME Group position peaked at $2.82B in Q3 2019.
1,791 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Capital Research Global Investors's 13F filing for Q1 2026, filed 13 May 2026.